Liquid dosage forms extemporaneously prepared from commercially available products–considering new evidence on stability

A Haywood, BD Glass - Journal of Pharmacy & …, 2013 - journals.library.ualberta.ca
Although the world's population is ageing and as a result of this an increasing number of
patients are experiencing difficulty in swallowing, there remains a lack of commercially …

[HTML][HTML] CDC Guidelines for the Prevention and Treatment of Anthrax, 2023

WA Bower - MMWR. Recommendations and Reports, 2023 - cdc.gov
This report updates previous CDC guidelines and recommendations on preferred
prevention and treatment regimens regarding naturally occurring anthrax. Also provided are …

Moxifloxacin hydrochloride

MMH Al Omari, DS Jaafari, KA Al-Sou'od… - Profiles of drug …, 2014 - Elsevier
A comprehensive profile of moxifloxacin HCl with 198 references is reported. A full
description including nomenclature, formulae, elemental analysis, and appearance is …

[HTML][HTML] Cellulose and its derivatives use in the pharmaceutical compounding practice

FD Marques-Marinho… - Cellulose-medical …, 2013 - intechopen.com
For centuries, the pharmaceutical profession has provided services of fundamental value to
society, such as the procurement, storage, compounding and dispensing of drugs. In recent …

Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children

KK Radtke, AC Hesseling, JL Winckler… - Clinical Infectious …, 2022 - academic.oup.com
Background Moxifloxacin is a recommended drug for rifampin-resistant tuberculosis (RR-TB)
treatment, but there is limited pediatric pharmacokinetic and safety data, especially in young …

Preparation of extemporaneous oral liquid in the hospital pharmacy

MRM Silva, LP Dysars, EP Santos… - Brazilian Journal of …, 2020 - SciELO Brasil
At the hospital, the pharmacist is constantly challenged to prepare extemporaneous
solutions from tablets, capsules or drug powder for patients unable to swallow, such as …

[HTML][HTML] Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB

JL Winckler, HR Draper, HS Schaaf… - … journal of tuberculosis …, 2020 - ncbi.nlm.nih.gov
Globally, there are an estimated 32 000 incident cases of rifampicin-resistant TB (RR-TB) in
children each year. 1 The treatment of RR-TB requires multi-drug regimens with second-line …

Biowaiver monograph for immediate-release solid oral dosage forms: moxifloxacin hydrochloride

NA Charoo, DB Abdallah, T Parveen… - Journal of …, 2020 - Elsevier
In this monograph, literature data is reviewed to evaluate the feasibility of waiving in vivo
bioequivalence testing and instead applying the Biopharmaceutics Classification System …

Exploring paediatric oral suspension development: Challenges, requirements, and formulation advancements

SS Gaikwad, JO Morales, NB Lande… - International Journal of …, 2024 - Elsevier
Oral suspension is the most preferred dosage form for the paediatric population because of
the difficulties related to solid medications, such as the swallowing limitations, bitter taste …

Photodegradation of moxifloxacin in aqueous and organic solvents: a kinetic study

I Ahmad, R Bano, SG Musharraf, S Ahmed… - Aaps Pharmscitech, 2014 - Springer
The kinetics of photodegradation of moxifloxacin (MF) in aqueous solution (pH 2.0–12.0),
and organic solvents has been studied. MF photodegradation is a specific acid-base …